Search

everythinglearnresearchcommunity

for

Search:↓

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

miR-200a reduces goose fibroblast growth by targeting PITX2 in the Wnt pathway.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Retinoids may help treat lupus nephritis and reduce steroid use.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

KeraGLO improves skin and hair health.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

GLI2 increases follistatin production in human skin cells.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

The document does not give specific results for hair loss treatment effectiveness.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

AMP-303 safely increases hair growth in men with hair loss.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

IL-15 promotes hair growth and protects hair follicles.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.